93 related articles for article (PubMed ID: 21861150)
1. Current trends in the etiology and diagnosis of HPV-related head and neck cancers.
Chai RC; Lambie D; Verma M; Punyadeera C
Cancer Med; 2015 Apr; 4(4):596-607. PubMed ID: 25644715
[TBL] [Abstract][Full Text] [Related]
2. What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?
Urban D; Corry J; Rischin D
Cancer; 2014 May; 120(10):1462-70. PubMed ID: 24578320
[TBL] [Abstract][Full Text] [Related]
3. A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancer.
Ong CJ; Shannon NB; Mueller S; Lek SM; Qiu X; Chong FT; Li K; Koh KKN; Tay GCA; Skanthakumar T; Hwang JSG; Hon Lim TK; Ang MK; Tan DSW; Tan NC; Tan HK; Soo KC; Iyer NG
Oncotarget; 2017 Oct; 8(45):79556-79566. PubMed ID: 29108335
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot study.
Aderhold C; Grobschmidt GM; Sauter A; Faber A; Hörmann K; Schultz JD
Oncol Lett; 2014 Sep; 8(3):1112-1118. PubMed ID: 25120668
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy of head and neck cancer. Current developments].
Schuler PJ; Hoffmann TK; Gauler TC; Bergmann C; Brandau S; Lang S
HNO; 2013 Jul; 61(7):559-72. PubMed ID: 23247754
[TBL] [Abstract][Full Text] [Related]
6. [Translational research in head and neck cancer. Biological characteristics and general aspects].
Dietz A; Wichmann G
HNO; 2011 Sep; 59(9):874-84. PubMed ID: 21861150
[TBL] [Abstract][Full Text] [Related]
7. [HPV-associated head and neck cancer. The basics of molecular and translational research].
Wittekindt C; Wagner S; Klussmann JP
HNO; 2011 Sep; 59(9):885-92. PubMed ID: 21769577
[TBL] [Abstract][Full Text] [Related]
8. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
Wittekindt C; Wagner S; Mayer CS; Klußmann JP
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
[TBL] [Abstract][Full Text] [Related]
9. High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.
Tehrany N; Kitz J; Rave-Fränk M; Lorenzen S; Li L; Küffer S; Hess CF; Burfeind P; Reichardt HM; Canis M; Beissbarth T; Wolff HA
Strahlenther Onkol; 2015 Jul; 191(7):566-72. PubMed ID: 25575976
[TBL] [Abstract][Full Text] [Related]
10. Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab.
Heiduschka G; Grah A; Oberndorfer F; Seemann R; Kranz A; Kornek G; Wrba F; Thurnher D; Selzer E
Strahlenther Onkol; 2014 Sep; 190(9):832-8. PubMed ID: 24715244
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.
Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
Acta Otolaryngol; 2012 Sep; 132(9):1006-12. PubMed ID: 22667340
[TBL] [Abstract][Full Text] [Related]
12. Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
Kao KJ; Chang KM; Hsu HC; Huang AT
BMC Cancer; 2011 Apr; 11():143. PubMed ID: 21501481
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics for RNomics.
Reiche K; Schutt K; Boll K; Horn F; Hackermüller J
Methods Mol Biol; 2011; 719():299-330. PubMed ID: 21370090
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
